Golden Throat Holdings Group Co Ltd 06896
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 3.86
- Day Range
- HKD 3.77–3.85
- 52-Week Range
- HKD 2.43–4.09
- Bid/Ask
- HKD 3.78 / HKD 3.81
- Market Cap
- HKD 2.80 Bil
- Volume/Avg
- 57,500 / 168,668
Key Statistics
- Price/Earnings (Normalized)
- 9.94
- Price/Sales
- 2.63
- Dividend Yield (Trailing)
- 9.50%
- Dividend Yield (Forward)
- 15.83%
- Total Yield
- 9.33%
Company Profile
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. It manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives revenue from Mainland China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 869
- Website
- http://www.goldenthroat.com
Comparables
Valuation
|
Metric
|
06896
|
02348
|
01672
|
|---|---|---|---|
Price/Earnings (Normalized) | 9.94 | 5.14 | — |
Price/Book Value | 1.64 | 0.58 | 0.56 |
Price/Sales | 2.63 | 1.43 | 23.84 |
Price/Cash Flow | 8.64 | 5.21 | — |
Price/Earnings
06896
02348
01672
Financial Strength
|
Metric
|
06896
|
02348
|
01672
|
|---|---|---|---|
Quick Ratio | 2.13 | 2.07 | 16.51 |
Current Ratio | 2.57 | 2.59 | 16.58 |
Interest Coverage | 32.49 | 1,084.97 | −1,693.40 |
Quick Ratio
06896
02348
01672
Profitability
|
Metric
|
06896
|
02348
|
01672
|
|---|---|---|---|
Return on Assets (Normalized) | 11.66% | 11.64% | −5.34% |
Return on Equity (Normalized) | 16.91% | 15.46% | −5.59% |
Return on Invested Capital (Normalized) | 13.47% | 14.62% | −9.56% |
Return on Assets
06896
02348
01672
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rxhrpmfs | Vcsxj | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Dwhvttds | Rfcgqbs | $74.3 Bil | |
HLN
| Haleon PLC ADR | Wbchrshr | Myqn | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cgjcnwgm | Qpztl | $19.1 Bil | |
VTRS
| Viatris Inc | Hkfzcxck | Kdgxs | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kysbpzlx | Vwtl | $11.7 Bil | |
CTLT
| Catalent Inc | Zwqyydjf | Vfffgw | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Tzvmglzb | Ctpp | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Gvfnhnjc | Ffzs | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qmklcfxc | Njqlmc | $3.3 Bil |